Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)

项目摘要 VECDor全球健康培训计划（GHTP）包括四个杰出的机构--范德比尔特（V）， 埃默里大学（E）、康奈尔大学（C）和杜克大学（D）--统称为VECD --拥有数十年的全球伙伴关系， 非洲首屈一指的LMIC研究机构（肯尼亚、赞比亚、坦桑尼亚、莫桑比克、埃塞俄比亚、加纳， 尼日利亚、卢旺达）、亚洲（印度、越南）、拉丁美洲（洪都拉斯、尼加拉瓜、危地马拉）和 加勒比（海地）。总的来说，VECDor资金充足的研究组合包括各种各样的， 传染性和非传染性疾病（NCDs）的补充主题。所有VECDor机构都有 在全球卫生培训方面进行了大量投资，这将继续最大限度地利用 NIH资源。VECDor的机构和教师有着悠久的全球参与历史， 成功部署和指导87名VECDor，证明了这一点 从2012年到2017年的高生产力学员。使用高效的支持中心，最大限度地 的资金，研究培训，并利用多种来源的财政和实物共同资助，我们将联系 与T32和其他NIH资助的培训项目以及少数民族机构合作伙伴一起选择和 从2017年至2022年部署80至100名美国和LMIC学员，为研究事业做出杰出的承诺。 VECDor将在整个联盟中实施战略指导和培训生支持计划，包括 在实地部署之前并在研究年之后继续进行的实质性准备阶段， 完成，以确保最高质量的研究出版物和科学会议的介绍， 最大限度地帮助受训人员获得研究和职业发展赠款。研究主题将 解决所有主题和感兴趣的地理区域的学员和NIH研究所和中心。我们将 通过长期监测和评估（M&E）计划记录该计划的影响， 所有学员的职业方向和产出，并将进一步完善我们现有的基于网络的工具，以分享 知识，促进当地和全球网络，加强和维持临床研究技能， 全球卫生研究员和校友。VECDor建立在我们的美国和全球合作伙伴的相互尊重基础上， 研究创新和指导的集体跟踪记录。结合我们最近在以下方面的丰富经验： 研究培训计划管理，全球主要疾病的强大研究资金基础 重要性、著名的国际研究培训合作伙伴和地点，以及加强机构共同资助 根据承诺，VECDor将继续培养21世纪全球卫生研究队伍的关键成员。 世纪，正如我们在现有的VECDor计划中所做的那样。

PROJECT SUMMARY The VECDor Global Health Training Program (GHTP) comprises four outstanding institutions – Vanderbilt (V), Emory (E), Cornell (C), and Duke (D) – collectively, VECD – with decades-long global partnerships with premier LMIC research institutions in Africa (Kenya, Zambia, Tanzania, Mozambique, Ethiopia, Ghana, Nigeria, Rwanda), Asia (India, Vietnam), Latin America (Honduras, Nicaragua, Guatemala), and the Caribbean (Haiti). Collectively, VECDor's well-funded research portfolio encompasses diverse and complementary topics in communicable and non-communicable diseases (NCDs). All VECDor institutions have made substantial investments in global health training, which will continue to provide maximal leveraging of NIH resources. VECDor institutions and faculty have a long history of global engagement, investigative accomplishment, and mentoring excellence, evidenced by successfully deploying and mentoring 87 VECDor highly productive trainees from 2012-2017. Using a highly efficient support center that maximizes the direction of funds to research training, and leveraging multiple sources of financial and in-kind co-funding, we will link with T32 and other NIH-funded training programs and with minority institution partners to select and deploy 80 to 100 US and LMIC trainees from 2017-2022 with outstanding promise for research careers. VECDor will implement a strategic mentoring and trainee support plan across the consortium, including a substantial preparation phase prior to field deployment and continuing after the research year is completed, to ensure the highest quality research publications and scientific meeting presentations and maximum trainee success in obtaining research and career development grants. Research themes will address all topic and geographical areas of interest to trainees and NIH Institutes and Centers. We will document the Program's impact through a long-term monitoring and evaluation (M&E) plan that tracks the career directions and outputs of all trainees and will further refine our existing web-based tools to share knowledge, foster local and global networking, and strengthen and sustain clinical research skills among global health fellows and alumni. VECDor is built on the mutual respect of our US and global partners and our collective track record of research innovation and mentorship. Combining our extensive recent experience in research training program management, robust research funding bases in major diseases of global significance, renowned international research training partners and sites, and enhanced institutional co-funding commitments, VECDor will continue to nurture key members of the global health research workforce of the 21st century, as we have done within the incumbent VECDor program.